...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.
【24h】

A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.

机译:一例孤立性室管膜下巨细胞星形细胞瘤:肿瘤中TSC2的两次体细胞击中,没有体细胞镶嵌的证据。

获取原文
获取原文并翻译 | 示例

摘要

Subependymal giant cell astrocytoma (SEGA) is a unique brain tumor arising in tuberous sclerosis complex (TSC), an autosomal dominant inherited phacomatosis. There are several case reports of solitary SEGA without any other manifestations of TSC. Usually these cases are thought to be forme fruste of TSC due to somatic mosaicism. However, no previous reports have used molecular methodology to fully investigate mutations in TSC genes or the possibility of somatic mosaicism. Here, we report a 20-year-old woman with a brain tumor. Pathological diagnosis was consistent with SEGA, but comprehensive clinical screening found no other lesions indicative of TSC. Molecular analysis of the tumor revealed loss of heterozygosity and allelic mutation (5228G>A, R1743Q) of TSC2. To detect the small fraction of mosaic mutation in somatic cells, we developed a highly sensitive new method: triple-nested polymerase chain reaction-restriction fragment length polymorphism. The identical TSC2 missense mutation was not detected in any other tissues from the same patient, including peripheral blood, buccal mucosa, urinary sediment, nail, and hair. According to these results, this patient should be considered as having SEGA that developed from two somatic hit mutations in TSC2, rather than being a TSC2 patient with a very small fraction of somatic mosaicism.
机译:室管膜下巨细胞星形细胞瘤(SEGA)是一种在结节性硬化症复合体(TSC)中出现的独特脑肿瘤,后者是常染色体显性遗传遗传性眼病。有几例孤立的SEGA病例报告,没有任何其他TSC表现。通常,由于体细胞镶嵌症,这些病例被认为是TSC的绝症。但是,以前没有报告使用分子方法来全面研究TSC基因的突变或体细胞镶嵌的可能性。在这里,我们报道了一名20岁的女性患有脑瘤。病理诊断与SEGA一致,但全面的临床筛查未发现其他提示TSC的病变。肿瘤的分子分析显示TSC2的杂合性丧失和等位基因突变(5228G> A,R1743Q)。为了检测体细胞中的一小部分镶嵌突变,我们开发了一种高度敏感的新方法:三重嵌套聚合酶链反应-限制性片段长度多态性。在同一患者的其他任何组织(包括外周血,颊粘膜,尿沉渣,指甲和头发)中均未检测到相同的TSC2错义突变。根据这些结果,该患者应被视为具有由TSC2中的两个体细胞命中突变形成的SEGA,而不是体细胞镶嵌性非常少的TSC2患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号